| |
| |
|
| Insider
Information: |
Fmr Corp |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
32 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
55,020,234 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$692,707,924 |
|
|
| Total
Shares |
55,020,234 |
|
|
| Total
Value |
$692,707,924 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -169.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ironwood Pharmaceuticals Inc |
IRWD |
Edward C. Johnson 3d, ... |
|
0 |
2012-07-10 |
2,340,891 |
Premium* |
|
|
Exa Corp |
EXA |
See Remark 1 |
2012-07-03 |
0 |
2016-09-30 |
0 |
Premium* |
|
|
Insmed Inc |
INSM |
Edward C. Johnson 3d, ... |
|
0 |
2013-07-22 |
2,221 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
See Remark 1 |
2015-03-05 |
0 |
2013-03-25 |
2,141,645 |
Premium* |
|
|
GT Advanced Technologies Inc |
GTAT |
Edward C. Johnson 3d |
|
0 |
2014-05-27 |
1,078,006 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
See Remark 1. |
2014-01-30 |
0 |
2014-08-01 |
1,457,994 |
Premium* |
|
|
Generac Holdings Inc. |
GNRC |
See Remark 1, 10% Owner |
2014-07-01 |
0 |
2014-07-01 |
763,071 |
Premium* |
|
|
Blueprint Medicines Corp |
BPMC |
See Remark 1 |
2015-05-05 |
0 |
2015-11-27 |
264,898 |
Premium* |
|
|
Coherus Biosciences, Inc. |
CHRS |
See Remark 1 |
|
0 |
2016-08-08 |
361,594 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
See Remark 1 |
|
0 |
2016-05-17 |
489,880 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-13 |
0 |
2017-08-11 |
326,617 |
Premium* |
|
|
Dimension Therapeutics, Inc. |
DMTX |
See Remark 1 |
|
0 |
2017-11-07 |
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
See Remark 1 |
2016-02-17 |
0 |
2017-03-13 |
243,508 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
See Remark 1 |
|
0 |
2018-08-08 |
606,356 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
See Remark 1 |
|
0 |
2017-07-03 |
1,715,935 |
Premium* |
|
|
Cogent Biosciences, Inc. |
COGT |
See Remark 1 |
2018-04-03 |
0 |
2018-04-03 |
23,240 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
See Remark 1, 10% Owner |
2018-04-23 |
0 |
2018-04-23 |
1,888,986 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
See Remark 1 |
2017-12-12 |
0 |
2017-12-12 |
783,216 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
See Remark 1 |
2018-01-29 |
0 |
2018-01-29 |
1,118,054 |
Premium* |
|
|
Precision Biosciences Inc |
DTIL |
See Remark 1 |
2019-04-01 |
0 |
2019-04-01 |
3,738,248 |
Premium* |
|
|
Orchard Therapeutics Plc |
ORTX |
See Remark 1, 10% Owner |
|
0 |
2021-02-19 |
4,099,540 |
Premium* |
|
|
Beam Therapeutics Inc. |
BEAM |
See Remark 1 |
2020-02-10 |
0 |
2024-02-14 |
1,235,511 |
Premium* |
|
|
Flywire Corp |
FLYW |
See Remark 1 |
|
0 |
2021-05-28 |
14,728,818 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
See Remark 1, 10% Owner |
2021-06-21 |
0 |
2022-07-12 |
570,729 |
Premium* |
|
|
Caribou Biosciences, Inc. |
CRBU |
See Remark 1 |
2021-07-27 |
0 |
2021-07-27 |
1,464,775 |
Premium* |
|
|
Rallybio Corp |
RLYB |
See Remark 1 |
2021-08-02 |
0 |
2021-08-02 |
1,694,388 |
Premium* |
|
|
Xilio Therapeutics, Inc. |
XLO |
See Remark 1 |
|
0 |
2021-10-26 |
30,780 |
Premium* |
|
|
Prime Medicine, Inc. |
PRME |
See Remark 1 |
2022-10-24 |
0 |
2022-10-24 |
4,228,589 |
Premium* |
|
|
Structure Therapeutics Inc. |
GPCR |
10% Owner |
2023-02-07 |
0 |
2023-10-02 |
785,364 |
Premium* |
|
|
Turnstone Biologics Corp. |
TSBX |
See Remark 1, 10% Owner |
2023-07-25 |
0 |
2023-07-25 |
4,939 |
Premium* |
|
|
Neumora Therapeutics, Inc. |
NMRA |
See Remark 1 |
|
0 |
2023-09-19 |
2,000,018 |
Premium* |
|
|
Sana Biotechnology, Inc. |
SANA |
|
|
0 |
2024-04-01 |
4,832,423 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SANA |
Sana Biotechnology, Inc. |
|
– – • |
2024-04-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,832,423 |
|
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – – |
2024-02-14 |
4 |
S |
$30.51 |
$27,496,912 |
I/I |
(900,000) |
1,235,511 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – – |
2024-02-13 |
4 |
S |
$30.28 |
$48,139 |
I/I |
(1,565) |
2,771,913 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2023-12-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(29,549) |
2,773,478 |
0 |
- |
|
| GPCR |
Structure Therapeutics In... |
10% Owner |
– – • |
2023-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
785,364 |
|
% |
|
| NMRA |
Neumora Therapeutics, Inc... |
See Remark 1 |
– – – |
2023-09-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,712,624 |
88,289 |
0 |
- |
|
| NMRA |
Neumora Therapeutics, Inc... |
10% Owner |
– – • |
2023-09-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,911,729 |
|
- |
|
| TSBX |
Turnstone Biologics Corp. |
See Remark 1 |
– – • |
2023-07-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,133,987 |
4,939 |
0 |
- |
|
| GPCR |
Structure Therapeutics In... |
See Remark 1 |
– – – |
2023-02-07 |
4 |
A |
$0.00 |
$0 |
I/I |
5,816,554 |
4,769,404 |
0 |
- |
|
| PRME |
Prime Medicine, Inc. |
See Remark 1 |
– – – |
2022-10-24 |
4 |
A |
$0.00 |
$0 |
I/I |
8,462,946 |
4,228,589 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-09-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,620) |
0 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-09-06 |
4 |
S |
$54.25 |
$29,892 |
I/I |
(551) |
0 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-09-06 |
4 |
A |
$0.00 |
$0 |
I/I |
551 |
551 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-08-05 |
4 |
S |
$60.50 |
$1,229,807 |
I/I |
(20,326) |
0 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-08-04 |
4 |
A |
$0.00 |
$0 |
I/I |
888,573 |
2,803,027 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-08-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,342,933) |
25,620 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
See Remark 1 |
– – • |
2022-07-12 |
4 |
S |
$19.98 |
$3,386,520 |
I/I |
(163,000) |
570,729 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
See Remark 1 |
– – • |
2022-07-01 |
4 |
S |
$15.66 |
$607,217 |
I/I |
(38,775) |
773,729 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
See Remark 1 |
– – • |
2022-06-30 |
4 |
S |
$15.21 |
$286,100 |
I/I |
(18,810) |
772,504 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
See Remark 1 |
– – • |
2022-06-29 |
4 |
S |
$15.50 |
$536,376 |
I/I |
(34,409) |
791,314 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-04-13 |
4 |
S |
$50.01 |
$981,205 |
I/I |
(19,466) |
0 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-04-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,084,861 |
2,490,515 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
See Remark 1 |
– – • |
2022-04-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,616,168) |
12,818 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
See Remark 1 |
– – • |
2022-03-09 |
4 |
S |
$29.01 |
$115,199 |
I/I |
(3,971) |
825,723 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
See Remark 1 |
– – • |
2022-02-09 |
4 |
S |
$29.46 |
$388,577 |
I/I |
(13,190) |
829,694 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
